10x Genomics, Inc. announced that it has started shipping the first two products powered by the GEM-X technology architecture, Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3. GEM-X is the next generation of the company's leading single cell technology architecture and is built on a new and improved microfluidic chip design, featuring the latest technological advancements and optimized reagents for superior performance and high reliability. GEM-X is exclusively available for use on Chromium X Series instruments and delivers important performance and workflow advantages, including: Substantially increased sensitivity: Detect up to two times more genes compared to on-market Chromium assays to gain a more comprehensive view of cellular heterogeneity; Built to scale: Two-fold increase in cells captured per channel; More cost effective: More than two-fold reduction in cost per cell; Enhanced data quality: Two-fold reduction in multiplet rate enabling high quality data at scale; Maximum sample recovery: Recovery of up to 80% of cells, improving capture efficiency and making it ideal for samples typically yielding few cells, such as tissue biopsies or previously flow sorted cells; Improved assay robustness: Redesigned microfluidics and optimized reagents for faster and more efficient cell partnering.